Source BioScience Limited is an international provider of integrated state of the art Laboratory Services and Products. Headquartered in the UK, with offices in UK, Europe and the USA, Source BioScience is privately held, having been acquired through a public to private transaction led by majority shareholders Harwood Capital LLP and Continental Investment Partners in September of 2016. Source BioScience PLC, was de-listed from the London Stock Exchange upon acquisition.